title: Traumatic intracerebral lesions without extracerebral haematoma in 218 patients.
abstract: 218 of the 852 patients in the HIT-2 study of head injury had intracerebral lesions only. They were analysed to get more information on the optimal treatment of these severely injured patients. The initial CT scans were reviewed to exclude patients with extracerebral lesions, and to make a radiological diagnosis of contusion, contusion under a depressed fracture, diffuse axonal injury, or intracerebral haematoma. Deterioration after admission to hospital was seen in 71% of patients. Patients with contusions, and contusions from depressed fractures in particular showed a worse outcome than expected, while patients with diffuse injury had a tendency to improve rather than to deteriorate. Patients with intracerebral haematoma seemed to improve if the mass was evacuated. Nimodipine had an impact only in patients with contusions. Our findings mandate surgical evacuation of contusions and intracerebral haematomas in patients with lesions larger than 20 ml who also have radiological signs of a mass effect. Regardless of an apparently good clinical state in the early phase, intracerebral lesions larger than 50 ml seemed to benefit from surgery as compared to nonsurgical treatment. The findings indicated that a further refinement of diagnostic criteria may enable individually tailored head injury treatment to interfere with most important pathogenic mechanisms. More accurate diagnoses will improve head injury treatment and outcome, and are a prerequisite for making successful pharmaceutical trials of head injury in the future.
authors.affiliation: Department of Neurosurgery, Karolinska Hospital, Stockholm, Sweden.
authors.forename: T
authors.initials: T
authors.lastname: Mathiesen
authors.forename: A
authors.initials: A
authors.lastname: Kakarieka
authors.forename: G
authors.initials: G
authors.lastname: Edner
mesh_terms: D000328:Adult; D001924:Brain Concussion / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D001925:Brain Damage, Chronic / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D016489:Head Injuries, Closed / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D009553:Nimodipine / Q000008:administration & dosage; D011183:Postoperative Complications / Q000175:diagnosis / Q000401:mortality / Q000517:prevention & control; D012887:Skull Fractures / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D002121:Calcium Channel Blockers; D009553:Nimodipine